Lawless speaks to Philadelphia Inquirer about bankruptcy protection and student loans

When student loan payments resumed in October, an op-ed in the Philadelphia Inquirer proposed a solution to help debtors: Restore bankruptcy rights to student loans. To make his case, the author of the piece spoke to bankruptcy expert Professor Robert Lawless about the history of bankruptcy protection for student loans. Lawless explained that although federal student loans are not currently permitted in bankruptcy filings, legislation that restores these rights would not contravene existing law. 

“Any law passed by both houses of Congress and signed by the president can amend the Bankruptcy Code,” said Lawless.

Lawless quoted in Reuters series on lasting effects of slavery

In their series on how the effects of slavery remain with us today, Reuters spoke to Professor Robert Lawless about the history of bankruptcy. The series, titled “Slavery’s Descendants” examines how slavery, the Jim Crow era, and racial discrimination put two different families (one white, one black) on very different economic paths. For part four, “American Dreams,” Lawless provides his expertise to explain racial discrepancies in bankruptcy cases, which have tended to have worse outcomes for Black debtors than for white debtors.

Lawless quoted in article on Shelby County bankruptcies

In the past year, Shelby County, Tennessee, has a record of six bankruptcies per 1,000 residents, a rate that tops the nation. With none of the other 100 largest counties in the United States having more than four per 1,000, the difference is not particularly close, either. In their investigation of this phenomenon, MLK50: Justice Through Journalism, a nonprofit Memphis newsroom, quoted Professor Robert Lawless. “(Shelby County) is a tremendous outlier,” said Lawless. “It’s hard to think of a reason why (that is) except for legal practice.… I have no question that there are attorneys in Memphis doing the right things by their client.… And I have no question that there are attorneys in Memphis that are taking advantage of people.”

Brubaker submits amicus brief in Purdue Pharma case

In the case of Harrington v. Purdue Pharma, pending before the U.S. Supreme Court, Professor Ralph Brubaker has submitted an amicus brief arguing “Courts have no power to approve” the bankruptcy plan submitted by Purdue Pharma. Joined in writing the brief by fellow bankruptcy experts Professor Bruce Markell of Northwestern and Professor Jonathan Seymour of Duke, Brubaker and his co-amici assert that approval of the Chapter 11 bankruptcy plan from Purdue Pharma is not permissible under established law and would represent a violation of claimants’ due-process rights. The brief suggests that the Court should repudiate the discharge plan in order to “put an end to the abusive ‘bankruptcy grifting’ that this case vividly illustrates.”

Robbennolt and Winship author perception of settlement article for APA

Though the record-breaking settlement Dominion received in its settlement with Fox News is frequently characterized as a “win” by commentators, the statement from Fox with the settlement was not apologetic, did not acknowledge any responsibility, and was not a retraction. In a new article written for the American Psychological Association, Professors Jennifer Robbennolt and Verity Winship, along with Jessica Bregant ’09 (now a professor at the University of Houston Law Center), dig into the psychological reasons people tend to infer that a settling defendant was responsible. Based on their research on settlements, the article provides a fascinating look at how perceptions can affect how lawsuits are settled.

USA Today quotes Brubaker on Rite Aid bankruptcy

In an attempt to restructure its more than $3 billion in debt and confront lawsuits alleging the company filled opioid prescriptions unlawfully, Rite Aid is reportedly preparing to file bankruptcy. In an article examining the company’s motivations for doing so and the potential ramifications of their bankruptcy, USA Today quoted Professor Ralph Brubaker, an expert in bankruptcy law. In his comments, Brubaker explained that customers would see almost no change should the retail chain declare Chapter 11 bankruptcy, but cited the example of Johnson & Johnson as how Rite Aid might not succeed in their efforts to limit liability.

Brubaker writes about Purdue Pharma’s appeal for Creditor Rights Coalition

As part of Creditor Rights Coalition’s “The Academics Speak Up” series, Professor Ralph Brubaker shared his thoughts on Purdue Pharma’s appeal to the U.S. Supreme Court in its bankruptcy proceedings. Brubaker made clear his feelings about the mechanisms by which Purdue was trying to discharge its debts in a direct and unsparing critique. “I am grateful for the tenacity of the U.S. Trustee and DOJ in calling out the utter impropriety of nondebtor-discharge practice, which has tainted the bankruptcy system and incited public outrage,” he wrote.

Johnson & Johnson facing uphill battle on bankruptcy, Brubaker tells Bloomberg

Johnson & Johnson’s attempts to use the bankruptcy of its subsidiary, LTL Management LLC, to settle claims that its talc-based products, like baby powder, caused cancer have failed once again, this time in US Bankruptcy Court for the District of New Jersey. In an article on Bloomberg Law, Professor Ralph Brubaker explained that the company’s first attempt to use bankruptcy, which was thrown out by the US Court of Appeals for the Third Circuit, makes an appeal on the second attempt very unlikely “to get much traction.”

Brubaker joins Bloomberg Intelligence podcast

Dating to his days in practice, Professor Ralph Brubaker has long held an interest in mass torts and bankruptcy that has developed into a rich and rewarding scholarly career. He shared his expertise in a feature interview on the Bloomberg Intelligence FICC Focus podcast, speaking in depth about what makes bankruptcy so appealing to defendants and corporate tortfeasors’ persistent efforts to exploit Chapter 11 protections. 

College of Law
504 East Pennsylvania Avenue
Champaign, IL 61820
(217) 333-0931